Schilderman P A, Rhijnsburger E, Zwingmann I, Kleinjans J C
Department of Health Risk Analysis and Toxicology, University of Limburg, Maastricht, The Netherlands.
Carcinogenesis. 1995 Mar;16(3):507-12. doi: 10.1093/carcin/16.3.507.
The food additive butylated hydroxyanisole (BHA) has been shown to induce gastrointestinal hyperplasia in rodents by an unknown mechanism. The relevance of this observation for human risk assessment is not clear. We therefore analysed the effect of BHA and its primary metabolites tert-butylhydroquinone (TBHQ) and tert-butylquinone (TBQ) on 8-oxo-deoxyguanosine formation and labelling induces in human lymphocytes in vitro. Analysis of culture medium and cell lysate fractions after administration of BHA or metabolites of BHA revealed that BHA and TBHQ undergo biotransformation in whole blood cultures. Moreover, TBQ can be reduced to TBHQ. While in cultures treated with BHA 50-60% of the dose administered was recovered, a much lower dose recovery was found in cultures treated with either TBHQ or TBQ. This indicates a considerable binding of these compounds to macromolecules. BHA and TBHQ, as well as TBQ, induced a dose-dependent increase in cell proliferation of phytohaemagglutinin-stimulated lymphocytes, 50 microM being the optimal dose. Since BHA is metabolized to TBHQ, it is not clear which compound is responsible for the proliferation enhancing effects observed in culture. Inhibition of IBHQ metabolism to its semiquinone radical by acetylsalicylic acid (ASA) reduced the increase in labelling indices induced by TBHQ. This indicates that this metabolic pathway is involved in the enhancement of cell proliferation induced by the hydroquinone. HPLC-ECD analysis of oxidative DNA damage in lymphocytes exposed to 10, 50 and 100 microM BHA, TBHQ or TBQ respectively showed that BHA was not capable of inducing oxidative DNA damage to a significant degree. TBQ and, in particular, TBHQ at a dose of 50 microM (the optimal dose for induction of cell proliferation), however, increased lymphocyte 7-hydroxy-8-oxo-2'-deoxyguanosine formation by 320 and 680% respectively. Inhibition of prostaglandin H synthase by ASA in cultures treated with TBHQ decreased the oxidation ratio significantly, confirming the significance of this enzyme system in the mechanism of toxicity of BHA.
食品添加剂丁基羟基茴香醚(BHA)已被证明可通过未知机制在啮齿动物中诱导胃肠道增生。这一观察结果与人类风险评估的相关性尚不清楚。因此,我们分析了BHA及其主要代谢产物叔丁基对苯二酚(TBHQ)和叔丁基醌(TBQ)对体外人淋巴细胞中8-氧代脱氧鸟苷形成和标记诱导的影响。在施用BHA或BHA代谢产物后对培养基和细胞裂解物组分进行分析发现,BHA和TBHQ在全血培养物中会发生生物转化。此外,TBQ可被还原为TBHQ。在用BHA处理的培养物中,施用剂量的50 - 60%得以回收,而在用TBHQ或TBQ处理的培养物中发现回收剂量要低得多。这表明这些化合物与大分子有相当程度的结合。BHA和TBHQ以及TBQ均诱导了植物血凝素刺激的淋巴细胞的细胞增殖呈剂量依赖性增加,50微摩尔是最佳剂量。由于BHA会代谢为TBHQ,因此不清楚哪种化合物导致了培养中观察到的增殖增强作用。乙酰水杨酸(ASA)对IBHQ代谢为其半醌自由基的抑制作用降低了TBHQ诱导的标记指数增加。这表明该代谢途径参与了对苯二酚诱导的细胞增殖增强过程。分别对暴露于10、50和100微摩尔BHA、TBHQ或TBQ的淋巴细胞中的氧化性DNA损伤进行高效液相色谱 - 电化学检测分析表明,BHA在很大程度上不能诱导氧化性DNA损伤。然而,TBQ,特别是剂量为50微摩尔(诱导细胞增殖的最佳剂量)的TBHQ,分别使淋巴细胞7 - 羟基 - 8 - 氧代 - 2'-脱氧鸟苷的形成增加了320%和680%。在TBHQ处理的培养物中,ASA对前列腺素H合酶的抑制作用显著降低了氧化率,证实了该酶系统在BHA毒性机制中的重要性。